The intensity of the psychedelic experience predicts its therapeutic effectiveness
A meta-analysis reveals that the intensity of the psychedelic experience predicts its effectiveness in treating depression and anxiety In recent years, psychedelic-assisted psychotherapy has emerged as a promising alternative in the treatment of various psychiatric disorders, especially mood disorders such as depression and anxiety. A recent meta-analysis published in Neuroscience & Biobehavioral Reviews has examined…
‘Common Side Effects’: any resemblance to reality is purely coincidental
The series ‘Common Side Effects’ combines psychedelia, criticism of the pharmaceutical industry, and brilliant animation in its first season On March 31st, the tenth and final episode of the first season of ‘Common Side Effects’ aired, a fabulous animated series from Adult Swim studio, written by Joseph Bennet, who also created ‘Scavengers Reign’, another amazing…
“Ketamine changed my life”: The ‘Trojan Horse’ of psychedelics revolutionizes mental health
Ketamine is a mysterious, versatile, and ambivalent substance. It has been used as an anesthetic in operating rooms since the 1960s, as a recreational drug in trance parties since the late 20th century, and more recently, it has become the only legally authorized psychedelic medication for mental health treatments—primarily, but not exclusively, for major depression….
“Psilocybin will be legalized in the United States in two to three years”
Psychologist, psychonaut and teacher, Iker Puente will also participate in Fuertedélica, the Psychedelic Conference of Fuerteventura. Around 500 therapists and scientists work in Spain in the field of psychedelics applied to mental health, most of them underground, according to Iker Puente‘s estimates. Iker knows this well, as many of them have trained at the Integrative…
Tantra and MDMA as vehicles to shake off centuries of Western puritanism
Raúl del Pino, author of the book ‘MDMA, Sex and Tantra’, will participate in Fuertedélica as a member of the round table ‘MDMA, from party to couch’, along with Fernando Caudevilla and José Carlos Bouso. Below, and to warm up, an extract from the first chapter of the mentioned book: “Under the effects of ecstasy,…
“Psychedelics will eventually be incorporated into the healthcare sector… but the system’s pace is glacial”
We analyze the present & future of psychedelic medicine with psychiatrist Juan París Juan París, psychiatrist and psychedelic researcher, attends Fuertedélica as a representative of the Spanish Society of Psychedelic Medicine (SEMPSI), one of the most active forums in the effort to integrate psychedelic substances into the Spanish healthcare system. París is one of the…
Hotel, Flights, Transfers: Everything You Need to Know to Happily Arrive at Fuertedélica
On the morning of November 22, the third edition of Fuertedélica begins in Corralejo. It will start with a free round table that will bring together some of the brightest young Spanish researchers in the field of psychedelics. Many of you are asking what you need to do to participate in the conference, stay in…
“Ibogaine allows you to break free from the chemical iron chain of methadone”
Anthropologist Antoniu Llort will share at Fuertedélica the results of the clinical trial with ibogaine for methadone detoxification, whose Phase II has just concluded at Sant Joan Hospital in Reus. In Llort’s words, it is “an exciting study that could mark a before and after in the treatment of methadone dependence.” Don’t miss Antoniu’s presentation…
“The refusal to authorize MDMA as a medication has done a huge favor to ‘underground’ therapy”
2024 was expected to be the year of the consolidation of the “psychedelic renaissance.” However, the FDA, the drug regulatory agency in the US, has rejected the approval of MDMA as a treatment for post-traumatic stress. José Carlos Bouso, scientific director of ICEERS and speaker at Fuertedélica, analyzes in this interview the causes behind this…
The Path to Pain Relief: Examining Ayahuasca’s Possible Benefits for Fibromyalgia Sufferers
Rafael Guimarães dos Santos is a world-renowned expert in scientific research on ayahuasca. A disciple of Jordi Riba at Sant Pau Hospital, Dos Santos leads several cutting-edge investigations with ayahuasca, ibogaine, and ketamine within the Department of Neuroscience and Behavioral Sciences at the University of São Paulo. In this interview, the Brazilian researcher gives us…
